Gloves.com Pledges to Donate 100 Million Medical Gloves to Help India Tackle PPE Shortages Caused by COVID Crisis
ACCESSWIRE
03 May 2021, 23:05 GMT+10
Texas based Gloves.com joins the United States and United Kingdom in pledging to provide necessary supplies and medical aid to India, where record COVID-19 cases are overwhelming hospitals.
AUSTIN, TX / ACCESSWIRE / May 3, 2021 / The White House has pledged to make more medical aid available to India in an effort to fight a record breaking spike in COVID-19 cases, but what support India will actually receive from the U.S. government has been vague. This week, the United Kingdom announced they are sending 600 pieces of medical equipment to India, including oxygen concentrators and ventilators. Austin, Texas based PPE provider Gloves.com is calling on world governments to do more, and pledging to donate up to 100 million medical gloves to hospitals in India to help lead by example.
Apollo Endosurgery Announces Appointments to Commercial Leadership Team
ACCESSWIRE
Kirk Ellis to Serve as Vice President of US Sales
Steve Bosrock to Serve as Vice President of Marketing & Medical Education
AUSTIN, TX / ACCESSWIRE / May 3, 2021 / Apollo Endosurgery, Inc. ( Apollo ) (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, today announced the appointments of Kirk Ellis as Vice President of US Sales and Steve Bosrock as Vice President of Marketing & Medical Education. Splitting the Vice President of Marketing and Sales into two roles will enhance Apollo s commercial acumen as the company pursues attractive growth prospects across three product lines. Both Mr. Ellis and Mr. Bosrock will begin their roles on May 10, 2021.
Lucky Minerals Updates Wayka Epithermal Gold Discovery With Geophysics
ACCESSWIRE
VANCOUVER, BC / ACCESSWIRE / (
Lucky or the
Company ) is pleased to announce it has continued work at the Wayka epithermal gold discovery at its 100% owned Fortuna Property ( Fortuna ). Fortuna comprises approximately 55,000 hectares in a known mineralized zone in southern Ecuador.
Lucky s CEO, Mr Francois Perron stated: Our recent Wayka discovery of mineralized vuggy silica hosted in volcanics at surface confirms we are in a high-sulfidation epithermal system. The geophysical data from El Buitre-Emma which revealed a magnetic low anomaly leading to the interpretation of a NNE structure has now been confirmed to coincide with the alteration at surface. The anomaly is presently shown to be at least 3 km long in a north-easterly direction and extends to the limit of the current data. Our teams are pursuing work in the field that will lead to a better understanding of this system both in term
Idaho Champion Gold Announces Early Exercise Warrant Incentive Program
ACCESSWIRE
03 May 2021, 21:31 GMT+10
CSE )-approved early exercise warrant incentive program (
Warrant Program ) intended to encourage the early exercise of the Company s 21,457,588 outstanding purchase warrants (
Warrants ) with a strike price of $0.15.
The Warrant Program will be open for a 30-day period (
Exercise Period ) and is only for Warrants priced at $0.15 with an expiry of May 17, 2024, June 7, 2024, August 27, 2024, February 14, 2025, February 26, 2025 and March 6, 2025.
Under the Warrant Program, each Warrant that is exercised during the Exercise Period will receive one (1) new common share purchase warrant (
Incentive Warrant ). Each Incentive Warrant will entitle the holder to purchase one common share of the Company (
Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada
ACCESSWIRE
The addressable market in Canada is estimated to be $80M CDN by 2022.
Tetra also applies for a Health Canada Cannabis Drug License
OTTAWA, ON / ACCESSWIRE / May 3, 2021 /
Tetra Bio-Pharma Inc. ( Tetra or the Company )(TSX:TBP)(OTCQB:TBPMF)(FRA:JAM1), a leader in cannabinoid-derived drug discovery and development today announced that the Company has been granted a Health Canada Drug Establishment License (DEL) to distribute REDUVO soft gel capsules in Canada. REDUVO is a synthetic THC-based soft gel capsule indicated in severe nausea and vomiting associated with cancer chemotherapy and is currently being assessed by Health Canada for the issuance of a Drug Identification Number (DIN). REDUVO, known as Marinol in the United States, has been approved as a regulated pharmaceutical drug by the U.S. Food and Drug Administration since 1985.